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Objectives: To estimate risk of comorbid depression on all-cause mortality over time among individuals
with diabetes.
Methods: The Medline, Cumulative Index to Nursing and Allied Health Literature, Cochrane Library, Embase
and Science Direct databases were searched through September 30, 2012. We limited our search to
longitudinal or prospective studies reporting all-cause mortality among those having depression and
diabetes, compared with those having diabetes alone that used hazard ratios (HRs) as the main outcome. Two
reviewers independently extracted primary data and evaluated the quality of studies using predetermined
criteria. The pooled random effects adjusted HRs were estimated using meta-analysis. The impact of
moderator variables on study effect size was examined with meta-regression.
Results: A total of 42,363 respondents from 10 studies were included in the analysis. Depression was
signiﬁcantly associated with risk of mortality (pooled HR=1.50, 95% conﬁdence interval=1.35–1.66). Little
evidence for heterogeneity was found across the studies (Cochran Q=13.52, P=.20, I2=26.03). No signiﬁcant
possibility of publication bias was detected (Egger's regression intercept=0.98, P=.23).
Conclusion: Depression signiﬁcantly increases the risk of mortality among individuals with diabetes. Early
detection and treatment of depression may improve health outcomes in this population.
© 2013 Elsevier Inc. Open access under CC BY-NC-ND license.Depression and Type 2 diabetesmellitus (DM) are among themost
prevalent chronic diseases in the United States. Approximately 15% of
adults in the U.S. will experience a major depressive episode at some
point in their life [1]. In 2010, 11.3% of U.S. adults aged 20 years or
older were diagnosed with diabetes [2], and this number is growing
exponentially. About 1.9 million people aged 20 years or older were
newly diagnosed with DM in 2010 [2].
Depression and Type 2 DM often co-occur. Up to 30% of individuals
with DM have a signiﬁcant number of depressive symptoms on
depression rating scales and 12–18%meet diagnostic criteria formajor
depression [3,4]. Patients with DM experience signiﬁcantly higher
rates of depression compared with their age- and gender-matched
counterparts [5]. Robust evidence supports the presence of bidirec-
tional interactions between depression and Type 2 DM. Depressive
episodes often begin early in adult life and are associated with a
higher risk of subsequent development of Type 2 diabetes. Comorbid
depression in patients with DM is strongly associated with burden of
DM symptoms [6], poor self-management and treatment adherence
[7], increase in health care services utilization and medical expendi-+1 412 383 7293.
-ND license.tures [8] and an increased risk of diabetes complications. Diabetes
complications such as myocardial infarction, amputation or loss of
vision can in turn precipitate or worsen depressive episodes.
Comorbid depression has been linked with increased mortality
among individuals with diabetes in some but not all studies. However,
no study has systematically reviewed this relationship. This paper
addresses that gap by estimating the risk of mortality in patients with
comorbid depression and diabetes compared to those with diabetes
alone from published and unpublished literature using meta-analysis.1. Methods
1.1. Search strategy
We conducted primary systematic literature searches using
combinations of keywords (depression, depressive disorders, major
depression, diabetes, diabetes mellitus and mortality). We ﬁrst
searched ﬁve databases: Medline, Cumulative Index to Nursing and
Allied Health Literature, Cochrane Library, Embase and Science Direct.
We limited our search to peer-reviewed articles published up to
September 30, 2012, with abstracts in English. We reviewed the
218 M. Park et al. / General Hospital Psychiatry 35 (2013) 217–225reference lists of eligible studies to increase the yield of our search.
Finally, we searched the Institute of Scientiﬁc Information Web of
Science database for studies citing the eligible studies and reviewed
their titles and abstracts to determine eligibility.
1.2. Selection criteria
To be included in the current analysis, a report needed to have a
longitudinal or prospective study design, report all-cause mortality
with hazard ratios (HRs) and include individuals with a measure of
depression [self-report questionnaire, structured psychiatric inter-
view, International Classiﬁcation of Diseases, Ninth Revision (ICD-9)
code or antidepressant prescription] and Type 1 or Type 2 diabetes
(self-report, ICD-9 code, laboratory result or prescription of glucose
lowering medication). We decided to have such broad inclusion
criteria because we preferred to err on the side of inclusiveness. To
maximize the generalizability of the results of the study, we excluded
studies with special populations such as those with a speciﬁc
complication of diabetes (such as a foot ulcer). We chose HRs to
include the effect of depression on all-cause mortality among
individuals with diabetes over time; this approach limited the analytic
technique of the study to Cox regression [9]. We did not use relative
risk (RR) or odds ratios (ORs) as proxy for HR in our analysis because
these do not account for time in the calculation. Furthermore, some
studies have shown that longer follow-up time increases the
divergence between RR, OR and HR [9]. In the event of multiple
publications, only the most recent manuscript was included.
1.3. Data extraction
M.P. and W.J.K. reviewed all the studies using a standardized data
extraction form. Discrepancies were resolved by consensus. Primary
data extracted for the current analyses included the method by which
depression and diabetes were diagnosed, study design, sample size,
setting, duration of the follow-up, outcome measures, covariates, HR
and 95% conﬁdence intervals (95% CIs). Our primary goal was to
compare the risk of all-cause mortality between those with diabetes
alone and those with comorbid depression and diabetes. Thus, when
four group results were presented (no DM/depression, depression
only, DM only and DM and depression), we calculated HRs of having
both DM and depression relative to those with DM only using the
method outlined by Altman and Bland [10]. If multiple risk estimates
were presented in a given manuscript, we selected the estimate that
most closely adjusted for demographic characteristics, behavioral risk
factors, comorbidity and DM status. For studies that presented graded
relationships (e.g., low, medium, high depressive symptoms), only the
cutting scores that correlated the highest with a probable major
depression diagnosis were used.
1.4. Assessment of validity
M.P. andW.J.K. independently rated each study on six components
of quality with an instrument similar to that used by Grote et al. [11].
The components of quality included clarity of description of the study
population, quality of diagnosis of depression, quality of diagnosis of
diabetes, appropriateness of statistical test, percentage of successful
recruitment of study population, adequacy of sample size, represen-
tativeness of study population, attrition rate reported and reﬂected
statistically and number of key potential confounders adjusted for in
multivariate analyses. The quality scores can range from 0 to 16;
discrepancies between reviewers were resolved by consensus.
1.5. Data synthesis and statistical analysis
M.P. and F.M.W. performed analyses using Review Manager 5 [12]
and Comprehensive Meta-Analysis [13]. The studies were weightedby the inverse variance methods described in the user's manual of the
Comprehensive Meta-Analysis. We used both a random-effect model
and a ﬁxed-effect model to pool the study results [14]. We pooled
adjusted HRs with a 95% CI [15–18]. Values greater than 1 indicate an
unfavorable impact of depression on mortality. Forrest plots [19] of
the estimates and 95% CIs, with the weight of each point estimate
indicated by the relative size of the marker, were used to visually
examine the range of effects. The heterogeneity of effect sizes was
assessed using the Cochran Q statistic (Q-value) and the I2 statistic. A
P value smaller than .01 was considered evidence of signiﬁcant
heterogeneity [20]. Higher I2 values (ranging between 0% and 100%)
indicate greater variability among the studies than would be expected
by chance alone [21].
Using meta-regression [22], we examined the impact of the
following moderator variables on study effect size: study populations
(community vs. clinical population), duration of follow-up, study site
(U.S. vs. non-U.S.), age and gender of the majority of subjects, number
of observations and quality scores of the report. We also conducted
leave-one-out analyses [23] for each study to examine the magnitude
of inﬂuence of each study on pooled mortality. Publication bias was
assessed using funnel plot, Egger's test [24,25], Duval and Tweedie's
trim-and-ﬁll approach [26] and classic fail-safe N [27].
2. Results
2.1. Study selection (Fig. 1)
The EndNote computer software was used to store search results,
organize them and identify duplicate citations. We identiﬁed 1236
records from the initial search. After duplicates were identiﬁed and
removed, 775 potentially relevant unique articles were retrieved. One
author (M.P.) reviewed and excluded 700 manuscripts that did not
refer to depression, diabetes or mortality in the title. When in doubt
whether to exclude or include a study based on the title, we included
the study for abstract review. Abstracts of the remaining 75 studies
were reviewed and 23 articles were selected for full text review. One
report that was currently under review in a peer-reviewed journal
was identiﬁed by an expert researcher and one additional record was
identiﬁed through bibliographic review. Two authors (M.P. and
W.J.K.) independently reviewed manuscripts. One study treated
depression scores as a continuous variable without a cutpoint; we
unsuccessfully contacted the ﬁrst author of the study for additional
analyses so that we could include the study in our analysis. Nine
reports published in English [28–36] and one in German [37] were
included in the meta-analysis. Fig. 1 presents the overall search ﬂow.
Table 1 shows the main characteristics of the studies. The character-
istics of the 13 studies excluded from the analysis [38–50] and the
reasons for exclusion appear in Table 2.
2.2. Participants
A total of 42,363 respondents with DM were included in this
meta-analysis. Among them, 5325 individuals had both depression
and DM and the remaining 37,038 cases had a diagnosis of DM
alone. The number of depression and DM cases in each study
ranged between 52 and 1657, whereas the number of DM only
cases in each study ranged between 401 and 13,694. Six out of 10
studies recruited study samples from the community, and other
studies used hospital or other primary care clinic settings. Seven
studies analyzed data from mixed-age populations and three
studies used older adult populations.
2.3. Measurement of depression and diabetes
Depression was measured by self-reported scales such as the
Center for Epidemiologic Studies Depression Scale (CES-D), Patient
Articles identified through 
database searching 
(n=1234) 
Additional articles identified 
through other sources 
(n=2)
Articles after duplicates removed 
(n=775) 
Abstracts screened 
(n=80) 
Articles excluded for not meeting 
inclusion criteria 
(n=57) 
Full text articles assessed 
for eligibility 
(n=23) 
Full-text articles excluded, with reasons (n=13) 
1. Multiple publications from same data set (n=2) 
2. Special population (n=2) 
3. No Hazard Ratios reported (n=3) 
4. Unable to compare the groups intended for this 
meta-analysis (n=3) 
5. Other reasons=3 
Studies included in 
quantitative synthesis 
(meta-analysis) 
(n=10) 
Articles excluded for not mentioning 
Depression, Diabetes, and Mortality  
(n=695) 
Fig. 1. Diagram of study selection for meta-analysis adapted from MOOSE Guideline [51].
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Depression measures were dichotomized with a cutoff point. Two
studies measured depression with CES-D with a cutoff point of 16
[28,29], two studies used the PHQ-9 diagnosis of major depression
[33,35], two studies used ICD-9 codes [31,32] and the other two
studies used other symptom severity instruments [30,37]. One study
used purchase of antidepressant as proxy for depression [36]. The
baseline depression status was included in the current meta-analysis.
To diagnose diabetes, ﬁve studies used blood tests [30,32,33,36,37],
two studies used patient self-report [28,29] and questionnaire [34],
two studies used ICD-9 codes [31,32] and one study used ﬁlled
prescription of insulin or an oral hypoglycemic agent as DM indicator
[33]. Whereas other studies examined individuals with Type 2 DM or
combined individuals with Type 1 and Type 2 DM, Ahola et al. [36]
studied individuals with Type 1 DM only.
2.4. Study outcomes
All studies reported adjusted HRs for all-cause mortality and four
studies also reported adjusted HRs for cardiovascular mortality. Ahola
et al. [36] reported the results for women and for men separately. We
treated these results as separate studies, instead of calculating pooled
HRs. The mean length of follow-up varied from 2 to 10 years. Five
studies reported data for 5 years or longer.
2.5. Statistics and covariates
All studies used Cox-regression models. Nine studies reported the
crude number of deaths or OR in addition to HR. All results wereadjusted for sociodemographic characteristics, and nine studies also
included covariates such as health behaviors (e.g., smoking and
physical activity) and clinical characteristics (e.g., comorbidity or
Charlson comorbidity score, diabetes complications) in the analysis.
However, speciﬁccharacteristics adjusted forvariedamongthestudies.
2.6. Effect of depression on mortality among those with diabetes (Table 3
and Fig. 2)
Depression was signiﬁcantly associated with increased risk of
mortality (pooled HR=1.48, 95% CI=1.36–1.61). Little evidence for
signiﬁcant heterogeneity was found across the studies (Cochran Q=
13.52, P=.20, I2=26.03). Four studies reported risk of cardiovascular
mortality in addition to all-cause mortality. Using a random-effect
model, depression was signiﬁcantly associated with increased risk of
cardiovascular mortality (pooled HR=1.21, 95% CI=1.05–1.37). We
found little evidence for signiﬁcant heterogeneity in cardiovascular
mortality across the studies (Cochran Q=3.96, P=.41, I2=0%).
2.7. Sensitivity tests
Weconducted three tests to examine thedegree of robustnessof the
above results. First, we compared the random-effect and ﬁxed-effect
models and did not ﬁnd a signiﬁcant difference in pooled HR between
the two (ﬁxed model pooled HR=1.48, 95% CI=1.36–1.60 vs. random
model pooled HR=1.50, 95% CI=1.35–1.66) (Table 3). The leave-one-
out analyses found that no single report unduly inﬂuenced the pooled
risk ratio estimates of the association between depression and all-cause
mortality among those with diabetes. Finally, we conducted a series of
Table 1
Description of studies included in the meta-analysis
Study # of cases Age at baseline
Both vs. DM alone
Follow-up
years
Women (%) Minority (%) Site Population Measures2 Covariates3 Quality
score
Both DM alone DM Depression
Black 2003 [28] 52 401 65 7 59.6 100 US Community Self-report CES-D
CIDI
1 13
Zhang 2005 [29] 1471 4121 64.2 (12.6) 10 61.3 23.7 US Community Self-report CES-DN16 1,2,3 14
Bruce 2005 [30] 401 872 63.2 (12.2) vs.
64.5 (10.7)
7.8 2.4 48.6 vs. 57.1 b10 Australia Community Blood test GHS 1,2,3 14.5
Richardson 2008 [31] 806 13,694 56 vs. 61.9 10 0 53.2 vs. 53.2 US Inpatient/outpatient ICD-9 code ICD-9 code 1,2,3 13
Katon 2008 [32] 1657 9047 71 (12.5) vs.
76.4 (8.2)
2 43 vs.58.7 b10 US Community DRG
ICD-9 code
Blood test
ICD-9 code 1,2,3 13.5
Lin 2009 [33] 493 3334 59.6 (12.8) vs.
64.7 (12.2)
4.41.5 58 vs. 46.9 20.4 vs. 21.3 US Inpatient/outpatient Blood Test
Physician gnosis
Filled pres ption
of insulin an oral
hypoglyce c agent
PHQ-9 probable major
depression diagnosis
1,2,3 16
Pieper 2011 [37] 165 976 67.0 (9.6) vs.
64.6 (11.5)
3.5 50 N/R Germany Inpatient/outpatient Blood test DSQ8 1,2,3 13
Pan 2011 [34] 1000 3873 54~79 6 100 b5 US Community Questionn e MHI551 1,2,3 14
Sullivan 2012 [35] 301 1326 62.26.7 4.671.45 39.6 34.9 US Inpatient/outpatient Physician gnosis PHQ-9 probable major
depression diagnosis
1,2,3 13
Ahola 2012 [36] 313 3103 43.411.4 9 40.1 vs. 45.9 b10 Finland Community Blood test Purchase of
antidepressant
1,2,3 14
1 The study reported only percentage (total diabetic population n=558). We estimated the numbers of cases using the percentage.
2 DRG, Diagnosis Related Groups; CIDI, Composite International Diagnostic Interview; GHS, General Health Status Questionnaire; DSQ, Depression Screening Questionnaire HI5, 5-ItemMental Health Index Subscale of 36-Item Short Form
Health Survey.
3 Covariates: 1, sociodemographic characteristics (e.g., age, gender, race/ethnicity, education, marital status, income or income/poverty ratio); 2, health behaviors (e.g., s king, physical activity, diet, drinking); 3, clinical characteristics
(e.g., condition, BMI, complications, blood pressure, depression medications).
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Table 2
Description of excluded studies
Citation Key ﬁndings Reason for exclusion
1 [38] Ismail K, Winkley K, Stahl D, Chalder T, Edmonds
M. A cohort study of people with diabetes and their
ﬁrst foot ulcer: the role of depression on mortality.
Diabetes Care. 2007; 30(6): 1473–1479.
Minor and major depressive disorders were associated
with an approximately threefold hazard risk for
mortality compared with no depression [HR 3.23 (95%
CI 1.39–7.51) and HR 2.73 (1.38–5.40), respectively].
Special population only: patients with ﬁrst
foot ulcer
2 [39] Bot M, Pouwer F, Zuidersma M, van Melle JP,
de Jonge P. Association of Coexisting Diabetes and
Depression With Mortality After Myocardial Infarction.
Diabetes Care. March 1, 2012 2012;35(3):503–509.
HRs for all-cause mortality were 1.38 (95% CI 1.00–1.90)
for patients with diabetes only and 2.90 (2.07–4.07) for
patients with both diabetes and depression.
Special population only: only patients post-MI
3 [40] Katon WJ, Rutter C, Simon G, et al. The Association
of Comorbid Depression With Mortality in Patients
With Type 2 Diabetes. Diabetes Care. November 2005
2005; 28(11): 2668–2672.
Minor depression was associated with a 1.67-fold
increase in mortality (P=.003), and major depression
was associated with a 2.30-fold increase (Pb .0001).
Same patient population as used with Lin et al.
(2009), but only 3-year follow-up
4 [41] Egede LE, Nietert PJ, Zheng D. Depression and
all-cause and coronary heart disease mortality among
adults with and without diabetes. Diabetes Care. Jun
2005;28(6):1339–1345.
Compared with the reference group, HRs for all-cause
mortality were diabetes present, no depression 1.88
(1.55–2.27); and diabetes present, depression present,
2.50 (2.04–3.08).
Same data set as paper of Zhang et al. (2005)
5 [42] Lee TA, Shields AE, Vogeli C, et al. Mortality rate
in veterans with multiple chronic conditions. J Gen
Intern Med. Dec 2007;22 Suppl 3:403–407.
Veterans with depression and DM experienced lower
5-year age-adjusted mortality rate than those with
diabetes only (OR 6.50, 95% CI 5.12–7.88 vs. OR 7.07,
95% CI 6.75–7.39).
Outcomes reported ORs, not HRs
6 [43] Rosenthal MJ, Fajardo M, Gilmore S, Morley JE,
Naliboff BD. Hospitalization and Mortality of Diabetes
in Older Adults: A 3-year prospective study.
Diabetes Care. February 1, 1998 1998;21(2):231–235.
Compared to older adults with DM only, those with
depression and DM experienced 1.32-fold increased
mortality in 5-year follow-up period (OR 1.32, 95% CI
1.02–1.70)
Outcomes reported as ORs, not HRs
7 [44] Black SA, Markides KS. Depressive symptoms
and mortality in older Mexican Americans.
Ann Epidemiol. Jan 1999;9(1):45–52.
The odds of having died among diabetics with high levels
of depressive symptoms (OR 4.03, 95% CI 2.67–6.11)
were three times that of diabetics without high levels of
depressive symptoms (OR 1.36, 95% CI 0.89–2.06).
Same data set as paper of Black et al. (2003)
8 [45] Prisciandaro JJ, Gebregziabher M, Grubaugh AL,
Gilbert GE, Echols C, Egede LE. Impact of psychiatric
comorbidity on mortality in veterans with type 2
diabetes. Diabetes Technol Ther. Jan 2011; 13(1):
73–78.
Only externalizing disorders were signiﬁcantly associated
with mortality: HR=1.22 (95% CI=1.02–1.47).
Depression was not clearly deﬁned. The authors
categorized psychiatric disorder into two groups:
internalizing and externalizing disorders and
aggregated data about individuals with depression
with other internalizing disorders (e.g., anxiety)
9 [46] Reynolds SL, Haley WE, Kozlenko N. The Impact of
Depressive Symptoms and Chronic Diseases on Active
Life Expectancy in Older Americans. American Journal
of Geriatric Psych. 2008; 16(5): 425–432
410.1097/JGP.1090b1013e31816ff31832e.
Depressive symptoms reduced active life expectancy by
6.5 years for young-old men (age 70), 3.2 years for
old-old men (age 85), 4.2 years for young-old women
and 2.2 years for old-old women.
Outcome was life expectancy not mortality
10 [47] Gallo JJ, Bogner HR, Morales KH, Post EP, Ten
Have T, Bruce ML. Depression, cardiovascular disease,
diabetes, and two-year mortality among older,
primary-care patients. The American journal of geriatric
psychiatry: ofﬁcial journal of the American Association
for Geriatric Psychiatry. 2005; 13(9): 748–755.
Persons with depression at baseline were more likely
to die at the end of the 2-year follow-up interval than
were persons without depression [relative odds
1.81, 95% CI 1.07–3.05; Wald χ2=4.96, df=1, P=.03]
Data on individuals with MI and diabetes were
aggregated. Thus, unable to compare mortality
among those with depression and DM and those
with DM only. The outcome was not reported as HR.
11 [48] Bogner HR, Morales KH, Post EP, Bruce ML.
Diabetes, depression, and death: a randomized
controlled trial of a depression treatment program
for older adults based in primary care (PROSPECT).
Diabetes Care. 2007;30(12):3005–3010.
Depressed patients with diabetes in the intervention
group were less likely to have died during the 5-year
follow-up interval than depressed diabetic patients
in usual care (adjusted HR 0.49, 95% CI 0.24–0.98)
Compares mortality rate between individuals
who received depression treatment and those
who were in comparison group. There was no
way to compare the mortality among those
with diabetes only and diabetes and depression.
12 [49] Landman GWD, van Hateren KJJ, Kleefstra N,
Groenier KH, Gans10 ROB, Bilo HJG. Health-Related
Quality of Life and Mortality in a General and Elderly
Population of Patients With Type 2 Diabetes
(ZODIAC-18). Diabetes Care. November 1, 2010
2010; 33(11): 2378–2382.
A 10-point-higher score on the Mental Component
Score decreased the risk for total mortality by 10%.
No clear depression cutoff point.
13 [50] Milano A, Singer R. Mortality in co-morbidity
(II)–excess death rates derived from a follow-up
study on 10,025 subjects divided into 4 groups with
or without depression and diabetes mellitus.
J Insur Med. 2007;39(3):160–166.
Appear to be using Egede's table for basis of
their ﬁndings. No original data.
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how each moderator is associated with the pooled HR. We calculated
regression coefﬁcients to describe the differences in HRs between the
groups categorized by covariate and P value of the coefﬁcient to
examine whether there is a linear relationship between HRs and the
covariate. Moderators examined include location of study (the U.S. vs.
the non-U.S.), quality scores, sampling frame (community vs. hospital/
clinic), length of follow-up, gender of the majority of sample (majority
women vs. majority men), age of sample (older adults vs. mixed-age)
and the number of observations. No signiﬁcant moderating effects
were found.2.8. Publication bias
We ﬁrst visually inspected the funnel plots [25], in which each
study's effect size was plotted against the standard error. The
asymmetry suggested that small studies with negative results might
not have been published. Duval and Tweedie's trim-and-ﬁll analysis
[26] suggested that two studies were missing in the left side of the
mean effect. The imputed HR using the trim-and-ﬁll approach was
1.46 (95% CI=1.30–1.63), which was slightly lower than our
estimation. The result of Egger's regression intercept approach [24]
indicated no signiﬁcant evidence of publication bias (intercept=0.99;
Table 3
Results from meta-analysis and meta-regression
N of
studies
Within group Between group
Pooled HRs 95% CI Cochran Q P value I2 (%) Cochran Q P value
Meta-analysis
Random effects 10 1.50 1.35–1.66
Fixed effects 10 1.48 1.36–1.60
Meta-regression
Study site 2.41 .12
U.S. 7 1.50 1.39–1.62 6.88 .33 13
Non-U.S. 3 1.36 1.39–1.62 0.51 .78 0
Study populations 0.08 .78
Community based 6 1.46 1.27–1.68 2.53 .47 0
Hospitals or clinics 4 1.66 1.38–1.63 10.55 .10 43
Populations 0.24 .63
Mixed age 7 1.47 1.33–1.62 8.73 .27 20
Older adults 3 1.56 1.24–1.96 4.80 .09 58
Gender 0.12 .73
Majority female 7 1.47 1.34–1.61 9.54 .22 27
Majority male 3 1.55 1.15–2.09 3.53 .17 43
Quality scores 0.28 .60
Less than or equal to 13.5 5 1.48 1.32–1.64 4.97 .29 19.5
Greater than N13.5 5 1.42 1.26–1.58 6.07 .30 17.7
Mean follow-up years 0.00 .97
Shorter than or equal to 6.5 years 5 1.45 1.29–1.62 2.43 .66 0.0
Longer than 6.5 years 5 1.45 1.29–1.60 8.89 .11 43.7
Number of observations 0.18 .67
Less than or equal to 5000 7 1.42 1.26–1.59 9.00 .25 22.2
Great than 5000 3 1.47 1.32–1.62 2.13 .34 6.2
222 M. Park et al. / General Hospital Psychiatry 35 (2013) 217–225two-tailed 95% CI,−0.74 to 2.72; P=.23). The result of classic fail-safe
N [27] suggested that 230 nil or null reports would be needed to raise
the P value associated with the average effect above an alpha level .05.
The fail-safe N value is larger than the recommended 5k+10 limit
(=60) [52]. The results of these four tests indicated that it is
unlikely that publication bias poses a signiﬁcant threat to the
validity of ﬁndings reported in the current analysis. Fig. 3 presents
the results of testing for publication bias.
3. Discussion
Comorbid depression in respondents with diabetes was associated
with an approximately 1.5-fold increase in risk of mortality among the
individuals with diabetes. Little evidence of heterogeneity was found
across studies and the results were consistent across several
sensitivity analyses including the leave-one-out analysis and the
analysis that compared random-effect and ﬁxed-effect models.
Moreover, results were also consistent when examining several
potential moderators including geographic location of study, gender,
community vs. hospital/clinic populations, age of population, lengthFig. 2. Forrest plot of studies included in meta-analysis of all-cause morof follow-up and qualities of the studies. Comorbid depression was
also associated with an approximately 20% higher risk of cardiovas-
cular mortality in these respondents with diabetes in the four studies
examining speciﬁc cause of death.
The results of the current analyses are consistent with the existing
literature [53], and to our knowledge, this study is the ﬁrst meta-
analysis to estimate risk of all-cause mortality associated with
comorbid depression among individuals with diabetes. Two studies
that did not meet the inclusion criteria because of examining only
subgroups of patients with DM who had speciﬁc complications were
excluded from this meta-analysis but also found increases inmortality
among those with comorbid depression and DM [38,39]. Ismail et al.
[38] and Bot et al. [39] examined individuals with their ﬁrst diabetes-
related foot ulcer and those with after myocardial infarction,
respectively. Both studies concluded that comorbid depression
increased mortality in these patient groups with diabetes complica-
tions (adjusted HR=2.73, 95% CI=1.38–5.40 and adjusted HR=2.10,
95% CI=1.32–3.35, respectively). Furthermore, the greater risk of
mortality in these patients with signiﬁcant diabetes complications
compared to the risk found in the above systematic review suggeststality associated with depression among individuals with diabetes.
 Duval and Tweedie's trim and fill method (Random Effects)
 Studies 
trimmed 
Point 
Estimate 95% CI Q-value 
Observed values (blue)  1.494 1.35, 1.65 13.50 
Adjusted Values (red) 2 1.456 1.30, 1.63 19.14 
 Egger's regression intercept: 0.986, 95% CI: -0.738, 2.710  
 Classic fail-safe N (The number of missing studies that would bring 
p-value to >alpha .05, 2-tailed) = 230 
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Fig. 3. Results of publication bias tests: funnel plot, trim-and-ﬁll method, Egger's regression intercept and classic fail-safe N.
223M. Park et al. / General Hospital Psychiatry 35 (2013) 217–225that the risk of comorbid depression for mortality may be higher
among those with greater severity of disease.
Depression may contribute to negative DM outcomes in several
ways. Katon [54] proposed a complex bidirectional relationship
between depression and Type 2 DM. Depression early in adult life is
a risk factor for subsequent development of diabetes [55]. The
increased risk of diabetes in patients with depression has been
hypothesized to be the result of maladaptive health risk behaviors
associated with depression such as smoking, obesity and lack of
physical exercise [54] as well as psychobiologic factors such as
increased cortisol levels, increased inﬂammatory factors [56] and
insulin resistance [57]. On the other hand, diabetes may increase risk
of depression or worsen the depression symptoms due to increased
symptom burden, diabetes complications causing functional impair-
ment and decreased quality of life, as well as vascular brain changes
secondary to diabetes. Comorbid depression has been found to impair
the ability to perform self-care activities necessary to control diabetes
by affectingmemory, energy level and executive function. Lack of self-
care and the psychobiologic changes associated with depression may
explain why individuals with comorbid depression experience
increased risk of macro- and micro-vascular complications [58] and
dementia [59]. Two publications allowed examination of whether
clinical characteristics (such as severity of diabetes and other medical
comorbidity) or health risk behaviors potentially mediated the risk of
depression on mortality: Lin et al. [33] and Pieper et al. [37]. When
clinical characteristics (such as number of diabetes complications)
were added to the models that initially only adjusted for demographic
characteristics, there was a decrease in point estimates of the HRs.
However, adding covariates related to health risk behaviors [such as
smoking, body mass index (BMI), physical inactivity and HbA1c] into
the previous models resulted in little change in the point estimates.
This suggests that the mechanism for the relationship between
depression and excess mortality in individuals with diabetes may be
largely psychobiological. As discussed earlier, because these covari-
ates are not uniform across the studies, head-to-head comparisons are
not possible. Further studies are sorely needed to have meaningful
conclusion about the mechanism of excess mortality associated with
depression in individuals with diabetes.
Prior literature found an approximately twofold increase of
mortality in patients with comorbid depression and each of the
following chronic medical conditions: stroke [60], coronary heart
disease [53], cancer [61] and chronic obstructive pulmonary disease
[62]. The current meta-analysis and literature support the ﬁnding that
comorbid depression increases the risk of mortality among those with
chronic disease. However, whether depression alone decreases life
expectancy is controversial. Reynolds et al. [46] reported thatdepression symptoms reduced total life expectancy signiﬁcantly but
controlling for chronic diseases eliminated the effect of depression
symptoms on mortality across age and gender groups. In contrast,
Cuijpers and Smit's meta-analysis of community studies [63]
concluded that having depression increased overall mortality by
almost twofold. However, their results did not control for lifestyle
factors or the presence of chronic conditions.
This systematic review of the literature revealed several major
important gaps in knowledge. Although some minority populations
experience an increased prevalence of both depression and diabetes
and a disproportionate burden of these illnesses [64–66], few
epidemiological studies provide conclusive data whether minority
populations experience greater mortality burden from comorbid
depression and DM compared to other populations. Among the 10
studies included in the current analysis, the study by Black et al. [28]
was the only one that reported the mortality risk associated with
comorbid depression and DM in a large aging Hispanic population.
They reported a higher risk of mortality associated with depression
and diabetes in this population compared to the other studies.
However, their study only adjusted for demographic characteristics
whereas the other studies also controlled for important other
potential confounders including health risk behaviors and disease
severity. There are also no studies in developing countries that have
examined the risk of comorbid depression in patients with Type 2
diabetes. Studies of diverse populations and in developing countries
are urgently needed to draw conclusions about potential disparities in
mortality burden associatedwith depression amongminority patients
with diabetes. Additionally, studies on Type 1 diabetes are also
needed. DM is a heterogeneous metabolic disease with distinctive
etiology and requirements for disease management. Thus, psycho-
logical reactions to onset of disease and burdens of disease may differ
between Type 1 and Type 2 DM. However, both Type 1 and Type 2 DM
require constant monitoring and self-management. Depression
adversely affects a person's ability to optimally perform these
functions and may increase mortality in individuals with DM
regardless of the type. In the current analysis, only the study of
Ahola et al. [36] examined populations with Type 1 diabetes. Other
community-based or primary-care-based studies examined popula-
tions with Type 2 DM only or those where over 90% of the sample
were likely to have Type 2 DM.
Considering the frequent multi-morbidity found in aging adult
populations, early intervention and treatment of depression may be
particularly important to improve mortality outcomes. Yet there is
limited data about whether screening and treating depression more
effectively would decrease premature death associated with DM. A
recent report [48] has found that older adults with depression and
224 M. Park et al. / General Hospital Psychiatry 35 (2013) 217–225diabetes who received more effective depression treatment in
primary care settings experienced a decrease in 5-year mortality
rates compared to those received usual primary care (adjusted HR=
0.49, 95% CI=0.24–0.98). However, three other studies that enhanced
depression care and improved depressive outcomes compared to
usual primary care in patients with diabetes and depression did not
ﬁnd a signiﬁcant decrease in mortality [67–69]. This was not an priori
hypothesis in these three studies that were likely underpowered to
examine mortality outcomes.
3.1. Limitations
The results of the current analyses should be interpreted in the
context of some limitations. First, despite our best efforts to capture all
publications that meet the criteria, we may have missed some studies
published in journals that are not indexed in the databases where we
conducted searches, those published in non-journal venues or studies
that have not been published. However, our results regarding
publication bias suggest that publication bias in very unlikely to
have affected our ﬁndings. Secondly, we pooled the adjusted HRs from
the studies reviewed using different covariates. As seen in Table 1, we
categorized covariates into three groups. However, each category was
deﬁned differently across the studies. Despite the evidence for strong
associations between mortality and characteristics such as severity of
diabetes, other comorbid conditions and health behaviors, not all
studies adjusted for all these covariates. Such variation in control for
potential confounders may have reduced compatibility of the studies
and introduced noise into our estimation. Nonetheless, the lack of
heterogeneity and negligible differences in the pooled adjusted HRs in
the random-effect and ﬁxed-effect models both suggest that these
differences in controlling for potential confounders across studies is
unlikely to have effected our ﬁndings.
4. Conclusion
The results of this meta-analysis provide robust evidence of the
adverse impact of comorbid depression on mortality among patients
with DM. Large-scale intervention studies are needed to test whether
decreasing the burden of comorbid depression in patients with Type 2
diabetes would decrease mortality rates.
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